Transparency & Investor Protection
We believe transparency builds trust. Access our regulatory filings, compliance policies, and understand the structures that protect your investment.
Veracor Capital operates under SEC Regulation D (Rule 506(b) and 506(c)) for accredited investor offerings and is filing under Regulation CF for retail investor access.
SEC Filings & Disclosures
Form ADV Part 2A — Firm Brochure
Detailed information about Veracor Capital's advisory services, fees, conflicts of interest, and disciplinary history.
In PreparationForm ADV Part 2B — Brochure Supplement
Supplemental information about supervised persons who provide investment advice.
In PreparationForm CRS — Client Relationship Summary
A brief summary of the services we offer, fees, conflicts of interest, and how to contact us.
In PreparationPolicies & Procedures
Anti-Money Laundering (AML)
Veracor Capital maintains a comprehensive AML compliance program in accordance with the Bank Secrecy Act and USA PATRIOT Act.
Know Your Customer (KYC)
All investors undergo identity verification and accreditation confirmation before capital acceptance.
Privacy & Data Protection
Investor data is encrypted, access-controlled, and handled in compliance with applicable privacy regulations.
Conflicts of Interest
We maintain policies and procedures to identify, disclose, and manage potential conflicts of interest.
Business Continuity
Robust disaster recovery and business continuity plans ensure uninterrupted operations and data protection.
Cybersecurity
Multi-layered security including encryption, access controls, breach monitoring, and regular audits.
Offering Structure
Regulation D — Accredited Investors
Our primary fund offerings are structured under SEC Regulation D, Rule 506(b) and 506(c), available exclusively to verified accredited investors. These offerings are exempt from SEC registration but are filed with the SEC via Form D.
Accredited Investor PortalRegulation CF — Retail Investors
Our upcoming Regulation CF offering will provide non-accredited (retail) investors access to healthcare investment opportunities starting at $1,000. The offering is currently in preparation and expected to launch in Q2 2026.
Learn About Reg CF